Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05934747 · ClinicalTrials.gov registry record · NA
Aim 3 Particle Swarm Optimization PIGD
A NA study of Parkinson's Disease and Parkinsonism, sponsored by University of Minnesota.
- Recruiting
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT05934747 is a NA study of Parkinson's Disease and Parkinsonism that is actively recruiting participants, run by University of Minnesota. The registered enrollment target is 30 participants, below the 596-participant average among 6 other Parkinson's Disease and Parkinsonism trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05934747, a NA study of Parkinson's Disease and Parkinsonism, is actively recruiting participants, sponsored by University of Minnesota.
- RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
In Parkinson's disease (PD) patients undergoing standard-of-care Deep Brain Stimulation (DBS) therapy, to compare the effect on Parkinson's symptoms of two different neurostimulator settings designed to differ from each other as much as possible with respect to how much they activate two different neuroanatomical structures: the axonal pathway from Globus Pallidus (GP) to Pedunculopontine Nucleus (PPN), and the axonal pathway from PPN to GP.
Conditions Studied
Interventions
- DEVICE DBS
Study Locations (1)
Minnesota
- University of Minnesota - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2024-03-19 |
| Est. Completion | 2027-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05934747
The ClinicalTrials.gov registry entry for NCT05934747 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 596-participant average among 6 other Parkinson's Disease and Parkinsonism trials with a reported enrollment target (95% lower). The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Parkinson's Disease and Parkinsonism appearing as the primary indexed condition, and to 1 intervention - of which DBS is the first listed.
NCT05934747 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT05934747 about?
NCT05934747 is a clinical study titled "Aim 3 Particle Swarm Optimization PIGD". In Parkinson's disease (PD) patients undergoing standard-of-care Deep Brain Stimulation (DBS) therapy, to compare the effect on Parkinson's symptoms of two different neurostimulator settings designed to differ from each other as much as possible with respect to how much they activate two different n...
What is the current status of trial NCT05934747?
This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2024-03-19. Estimated completion is 2027-06-30.
What conditions does trial NCT05934747 study?
This clinical trial studies the following conditions: Parkinson's Disease and Parkinsonism.
What interventions are being tested in trial NCT05934747?
The interventions under investigation include: DBS (DEVICE).
Who is sponsoring clinical trial NCT05934747?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05934747 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Parkinson's Disease and Parkinsonism
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Sleep-specific DBS Therapy in Parkinson's Disease
RECRUITING · NA
-
Blood Flow Restriction for Optimizing Balance in Parkinson's Disease
RECRUITING · NA
-
Community Outreach for Palliative Engagement -- Parkinson Disease
ACTIVE NOT RECRUITING · NA
-
STEM-Parkinson's Disease
COMPLETED · NA
-
Colonoscopic Detection of Phosphorylated Alpha-synuclein for Parkinson's Diagnosis
RECRUITING
-
Trial of Parkinson's And Zoledronic Acid
ACTIVE NOT RECRUITING · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.